Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (138 total)
-
Creator: Foeller, Megan E., Carolina Carvalho Ribeiro do Valle, Timothy M. Foeller, Olufemi T. Oladapo, Elin Roos, and Anna E. Thorson.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-05-06
Description: The outbreaks of Ebola virus between 2014 and 2020 have drawn attention to knowledge gaps related to Ebola virus disease in pregnant women. The aim of this study was to systematically evaluate available data on pregnant and lactating women with acute… -
Creator: Tapia, Milagritos D., Samba O. Sow, Khardiata D. Mbaye, Aliou Thiongane, Birahim P. Ndiaye, Cheikh T. Ndour, Souleymane Mboup, Babajide Keshinro, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche, Kwadwo A. Koram, Kwaku P. Asante,…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-03-19
Description: During the large 2013–16 Ebola virus outbreak caused by the Zaire Ebola virus, about 20% of cases were reported in children. This study is the first, to our knowledge, to evaluate an Ebola vaccine in children younger than 6 years. -
Creator: Tapia, Milagritos D., Samba O. Sow, Birahim P. Ndiaye, Khardiata D. Mbaye, Aliou Thiongane, Cheikh T. Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Gideon A. Akintunde, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche,…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-03-19
Description: The 2014 Zaire Ebola virus disease epidemic accelerated vaccine development for the virus. -
Creator: Bavari, Sina, and Patrick L. Iversen.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-03-19
Description: Two phase 2 randomised clinical trials evaluating ChAd3-EBO-Z administered to healthy adults in Cameroon, Mali, Nigeria, and Senegal and healthy children in Mali and Senegal are reported by Milagritos Tapia and colleagues in The Lancet Infectious… -
Creator: Dean, Christina L., Jay W. Hooper, John M. Dye, Samantha E. Zak, Scott A. Koepsell, Laurence Corash, Richard J. Benjamin, Steve Kwilas, Shannon Bonds, Anne M. Winkler, and Colleen S. Kraft.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-03-04
Description: In 2014, passive immunization by transfusion of Ebola convalescent plasma (ECP) was considered for treating patients with acute Ebola virus disease (EVD). -
Creator: Jacob, Shevin T., Ian Crozier, William A. Fischer, Angela Hewlett, Colleen S. Kraft, Marc-Antoine de La Vega, Moses J. Soka, Victoria Wahl, Anthony Griffiths, Laura Bollinger, and Jens H. Kuhn.
Subject: General
Item Type: Publication
Date Last Updated: 2020-02-20
Description: Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV). -
Creator: Rojek, Amanda M., Shevin T. Jacob, and Jake Dunning.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-03
Description: Since the onset of the west Africa Ebola virus outbreak, there has been remarkable progress in efforts to provide patients with improved supportive care and access to experimental treatments. -
Creator: ASPR TRACIE
Subject: Infection Control
Item Type: Hyperlink
Date Last Updated: 2018
Description: Purpose: The Hospital Personal Protective Equipment (PPE) Planning Tool is designed to help hospitals determine approximate minimum PPE needs based on special pathogen category and a number of facility specific variables. Calculators are included for… -
Creator: CDC
Subject: General
Item Type: Video
Date Last Updated: 2019-09-05
Description: Welcome to “We Were There,” a quarterly lecture series featuring past and present CDC researchers as they share their personal perspectives on historically important, CDC-led epidemiologic and laboratory investigations. This series will provide… -
Creator: NYC Health + Hospitals
Subject: Emergency Management
Item Type: Guide
Date Last Updated: 2023-12-15
Description: Matrix with response to different special pathogens.
